Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Apoptosis plays an important role in intervertebral disc degeneration (IDD). Overwhelming evidence indicates that
RASSF7
is essential for cell growth and apoptosis. Recently, it has been noted that the JNK signaling can be negatively regulated by suppressing phosphorylated-
MKK7
activation during pro-apoptosis. We aimed to investigate the
RASSF7
expression level in human degenerative nucleus pulposus (NP) cells and non-degenerative NP cells and the link between
RASSF7
-JNK with NP cells apoptosis. We harvested NP tissues from 20 IDD patients as disease group and 8 cadaveric donors as normal controls. We detected
RASSF7
expression by Real-time-PCR and western blotting. Consequently, we found that the expression of
RASSF7
was higher in non-degenerative group than in degenerative group (P<0.05). Overexpression of
RASSF7
in degenerative NP cells led to decreased apoptosis rate than that in scramble group (P<0.05). Collectively, our findings suggest that
RASSF7
plays an important role in human IDD and
RASSF7
might be potentially developed as a curative agent.
...
PMID:RASSF7 expression and its regulatory roles on apoptosis in human intervertebral disc degeneration. 2688 87
Disrupted in schizophrenia 1 (DISC1) is known as a high susceptibility gene for schizophrenia. Recent studies have indicated that schizophrenia might be caused by glia defects and dysfunction. However, there is no direct evidence of a link between the schizophrenia gene DISC1 and gliogenesis defects. Thus, an investigation into the involvement of DISC1 (a ubiquitously expressed brain protein) in astrogenesis during the late stage of mouse embryonic brain development is warranted. Here, we show that suppression of DISC1 expression represses astrogenesis in vitro and in vivo, and that DISC1 overexpression substantially enhances the process. Furthermore, mouse and human DISC1 overexpression rescued the astrogenesis defects caused by DISC1 knockdown. Mechanistically, DISC1 activates the RAS/
MEK
/ERK signaling pathway via direct association with
RASSF7
. Also, the pERK complex undergoes nuclear translocation and influences the expression of genes related to astrogenesis. In summary, our results demonstrate that DISC1 regulates astrogenesis by modulating RAS/
MEK
/ERK signaling via
RASSF7
and provide a framework for understanding how DISC1 dysfunction might lead to neuropsychiatric diseases.
...
PMID:DISC1 regulates astrogenesis in the embryonic brain via modulation of RAS/MEK/ERK signaling through RASSF7. 2728 8
The Ras-association domain family (RASSF) proteins have been involved in many important biological processes.
RASSF7
is recently reported to be up-regulated in several types of cancer. However, the function of
RASSF7
remain unknown in human cancers. To explore the role of
RASSF7
in hepatocellular carcinoma (HCC) cells proliferation and molecular mechanism.
RASSF7
expression was examined using public database TCGA, qRT-PCR and Western blot. The correlation between
RASSF7
and clinicopathological features was measured. Overexpression and silencing of
RASSF7
were performed to measure the impact on HCC cell proliferation, cell cycle and apoptosis. Futhermore, the molecular mechanism of
MEK1
/2-ERK1/2 signaling pathway regulation by
RASSF7
was explored.
RASSF7
was significantly up-regulated in HCC tissues and cell lines, and correlated with AFP, poor tumor histology and T stage. Overexpression of
RASSF7
promoted HCC cell proliferation, drived G1-S phase cell cycle transition and inhibited apoptosis. Knockdown of
RASSF7
suppressed cell growth, induced G1-S phase cell cycle arrest and cell apoptosis. Furthermore, our findings also demonstrated that
RASSF7
promoted HCC cell proliferation through activating
MEK1
/2-ERK1/2 signaling pathway. Taken together, this study provides a novel evidence for clinical significance of
RASSF7
as a potential biomarker, and demonstrates that
RASSF7
-
MEK1
/2-ERK1/2 signaling pathway might be a novel pathway involved in HCC progression.
...
PMID:RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma. 2972 97